TIDMODX

RNS Number : 1062O

Omega Diagnostics Group PLC

27 January 2023

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Director/PDMR Shareholding

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that on 26 January 2023 it received notification that Jag Grewal, Chief Executive Officer, and Chris Lea, Chief Financial Officer, had each purchased 1,000,000 ordinary shares of 4 pence each in the Company ("Ordinary Shares"), at a price of 3.4839 pence each.

A summary of each Directors resultant holdings is below:

 
  Director     Board Position    Existing number of      Ordinary Shares       Total beneficial holding of Ordinary 
                                   Ordinary Shares          Purchased           Shares following these acquisitions 
                                                                             Number of Ordinary     Approximate % of 
                                                                                   Shares           Company's issued 
                                                                                                      share capital 
                                                                            -------------------- 
 Jag Grewal    CEO                    1,025,834             1,000,000             2,025,834              0.85 % 
              ----------------  --------------------  --------------------  --------------------  -------------------- 
 Chris Lea     CFO                    1,030,908             1,000,000             2,030,908               0.85% 
              ----------------  --------------------  --------------------  --------------------  -------------------- 
 

Contacts:

 
 Omega Diagnostics Group PLC                                                                        www.omegadx.com 
 Jag Grewal, Chief Executive Officer                                                                via Walbrook PR 
 Chris Lea, Chief Financial Officer 
 
 
 finnCap Ltd                                                                                     Tel: 020 7220 0500 
 Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance) 
 Alice Lane/Charlotte Sutcliffe (ECM) 
 
 
 Walbrook PR Limited                                                     Tel: 020 7933 8780 or omega@walbrookpr.com 
 Paul McManus                                                                                    Mob: 07980 541 893 
 Lianne Applegarth                                                                               Mob: 07584 391 303 
 Sam Allen                                                                                       Mob: 07502 558 258 
 
 

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition .

www.omegadx.com

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

 
      Details of the person discharging managerial responsibilities 
  1    / person closely associated 
 a)   Name                       Jag Grewal 
     -------------------------  ------------------------------------- 
      Reason for the notification 
  2 
     ---------------------------------------------------------------- 
 a)   Position/status            Chief Executive Officer 
     -------------------------  ------------------------------------- 
 b)   Initial notification       Initial Notification 
       /Amendment 
     -------------------------  ------------------------------------- 
      Details of the issuer, emission allowance market participant, 
  3    auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                       Omega Diagnostics Group PLC 
     -------------------------  ------------------------------------- 
 b)   LEI                        2138007U9P4BTZTYIR92 
     -------------------------  ------------------------------------- 
      Details of the transaction(s): section to be repeated for 
  4    (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     ---------------------------------------------------------------- 
 a)   Description                Ordinary Shares of 4 pence each 
       of the financial 
       instrument, 
       type of instrument 
 
       Identification             ISIN: GB00B1VCP282 
       code 
     -------------------------  ------------------------------------- 
 b)   Nature of                  Ordinary Shares purchased 
       the transaction 
     -------------------------  ------------------------------------- 
 c)   Price(s) and                   Price(s)      Volume(s) 
       volume(s)                                   ---------- 
                                    3.4839 pence    1,000,000 
                                   --------------  ---------- 
     -------------------------  ------------------------------------- 
 d)   Aggregated                 See above 
       information 
 
 
       -Aggregated 
       volume 
 
 
       - Price 
     -------------------------  ------------------------------------- 
 e)   Date of the                26.01.2023 
       transaction 
     -------------------------  ------------------------------------- 
 f)   Place of the               London Stock Exchange 
       transaction 
     -------------------------  ------------------------------------- 
 
 
      Details of the person discharging managerial responsibilities 
  1    / person closely associated 
 a)   Name                       Chris Lea 
     -------------------------  ------------------------------------- 
      Reason for the notification 
  2 
     ---------------------------------------------------------------- 
 a)   Position/status            Chief Financial Officer 
     -------------------------  ------------------------------------- 
 b)   Initial notification       Initial Notification 
       /Amendment 
     -------------------------  ------------------------------------- 
      Details of the issuer, emission allowance market participant, 
  3    auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                       Omega Diagnostics Group PLC 
     -------------------------  ------------------------------------- 
 b)   LEI                        2138007U9P4BTZTYIR92 
     -------------------------  ------------------------------------- 
      Details of the transaction(s): section to be repeated for 
  4    (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     ---------------------------------------------------------------- 
 a)   Description                Ordinary Shares of 4 pence each 
       of the financial 
       instrument, 
       type of instrument 
 
       Identification             ISIN: GB00B1VCP282 
       code 
     -------------------------  ------------------------------------- 
 b)   Nature of                  Ordinary Shares purchased 
       the transaction 
     -------------------------  ------------------------------------- 
 c)   Price(s) and                   Price(s)      Volume(s) 
       volume(s)                                   ---------- 
                                    3.4839 pence    1,000,000 
                                   --------------  ---------- 
     -------------------------  ------------------------------------- 
 d)   Aggregated                 See above 
       information 
 
 
       -Aggregated 
       volume 
 
 
       - Price 
     -------------------------  ------------------------------------- 
 e)   Date of the                26.01.2023 
       transaction 
     -------------------------  ------------------------------------- 
 f)   Place of the               London Stock Exchange 
       transaction 
     -------------------------  ------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGCGDBXXDDGXR

(END) Dow Jones Newswires

January 27, 2023 04:36 ET (09:36 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Omega Diagnostics Charts.